Notices
Essential Drugs Division
Re-tender for the Procurement of Anti Haemophilia Drugs (ANTI HAEMOPHILIC FACTOR VIII with VON WILLEBRAND FACTOR) for the year 2025-26
Essential Drugs Division
E-tender for the Procurement of Standard Half-life and Extended Half Life Recombinant Anti Haemophilic Factor VIII for the year 2025-26 –Technical Bid Evaluation – Defects noticed/status– Published
Essential Drugs Division
List of Selected/Rejected Bidders/Products for Price Bid Evaluation of E-tender for the Procurement & supply of Insecticides for NVBDCP
Essential Drugs Division
List of Selected/Rejected Bidders/Products for Price Bid Evaluation of E-tender for the Procurement & supply of Diflubenzurone-Insect Growth Regulator-Larvicide for surveillance and control of communicable Diseases under Plan Fund for the year 2025-26
Essential Drugs Division
List of selected/ rejected bidder/product for price bid evaluation of e-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for NVBDCP for the year 2024-25
Essential Drugs Division
List of selected/ rejected bidder/product for price bid evaluation of e-Tender for the Procurement of Chlorine Tablets for Surveillance & control of Communicable diseases under plan fund for the year 2025-26
Essential Drugs Division
Re-tenders for the Procurement of Drugs/Supplies for the year 2026-27 - Cancellation of Re -Tenders
Essential Drugs Division
E-tender for the Procurement of drugs for the year 2026-27 - Price Bid evaluation- Final Bid Status Published
Essential Drugs Division
e-tender for theprocurement of drugs/supplies for theb year 2026-27 - Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for theprocurement of Specialty Drugs for theb year 2026-27 - Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for theprocurement of ANTI CANCER DRUGS for the year 2026-27 - Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for the procurement of ANTI CANCER DRUGS for theb year 2026-27 - Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for the procurement of ANTI CANCER DRUGS for theb year 2026-27 - Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for the procurement of ANTI CANCER DRUGS for theb year 2026-27 - Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for the Procurement of Biolarvicide: Bacillus Thuringiensis var Israeliensis (BTI) Serotype.H-14 for NVBDCP for the year 2024-25
Essential Drugs Division
e-Tender for the Procurement of Chlorine Tablets for Surveillance & control of Communicable diseases Under plan fund for the year 2025-26
Essential Drugs Division
E-tender for the Procurement & supply of Diflubenzurone-Insect Growth Regulator-Larvicide for surveillance and control of communicable Diseases under Plan Fund for the year 2025-26
Essential Drugs Division
Technical Bid Evaluation of e-Tender for the Procurement of Test kits for NVBDCP 2024-25 & PLAN FUND 2025-26
Essential Drugs Division
Re-TENDER DOCUMENT FOR THE PROCUREMENT OF ANTI-HAEMOPHILIA DRUGS(FACTOR VIII WITH VON WILLEBRAND FACTOR 250 IU)
Essential Drugs Division
KMSCL – E-tender for the Procurement & supply of Insecticides for NVBDCP - Technical Bid Evaluation– Status Published – Reg
Essential Drugs Division
Re-tender for the Procurement of Insecticides for surveillance and control communicable Diseases under Plan Fund for the year 2025-26"vide e-tender No. KMSCL/ED/INS-PLAN/RT/2026/004 DATED.21.02.2026.
Essential Drugs Division
KMSCL- e-tender For the Procurement of BLEACHING POWDER for the year 2026-27
Essential Drugs Division
KMSCL - E-tender for the Procurement of Anticancer Drugs for the year 2026-27 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published - reg
Essential Drugs Division
KMSCL - E-tender for the Procurement of Anticancer Drugs for the year 2026-27 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published - reg
Essential Drugs Division
KMSCL - E-tender for the Procurement of Drugs for the year 2026-27 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published - reg
Essential Drugs Division
KMSCL - E-tender for the Procurement of Drugs/Supplies for the year 2026-27 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published - reg
Essential Drugs Division
KMSCL - E-tender for the Procurement of Specialty Drugs for the year 2026-27 - Price Bid Evaluation – Notice on Supplier wise Rate Quoted and Provisional Bid Ranking Status - Published - reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Standard Half-life and Extended Half Life Recombinant Anti Haemophilic Factor VIII for the year 2025-26
Essential Drugs Division
KMSCL - e-Tender for the Procurement of Drugs/ Supplies for the year 2026 -27 - Technical Bid Evaluation – Notice on List of selected/rejected bidders/products for Price Bid Evaluation - Amendment Published
Essential Drugs Division
eTender Document for the Procurement of Test Kits For Surveillance & Control of Communicable Diseases under Plan Fund and NVBDCP
Essential Drugs Division
KMSCL - e-Tender for the Procurement of Drugs for the year 2026 -27 - Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
KMSCL - E-tender for the Procurement of Specialty Drugs for the year 2026 - 27 - Technical Bid Evaluation - List of selected/rejected bidders/products for price bid evaluation - Published
Essential Drugs Division
KMSCL - E-tender for the Procurement of Anticancer Drugs for the year 2026- 27 -Technical Bid Evaluation - List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
E-tender for the Procurement of Anticancer Drugs for the year 2026-27 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
e-Tender for the Procurement of Anticancer Drugs for the year 2026 -27 - Technical Bid Evaluation - Defects Noticed/ Status - Published - reg.
Essential Drugs Division
e-Tender for the Procurement of Anticancer Drugs for the year 2026 -27 - Technical Bid Evaluation - Defects Noticed/ Status - Published - reg
Essential Drugs Division
e-Tender for the Procurement of Drugs/supplies for the year 2026 -27 - Technical Bid Evaluation - Defects Noticed/ Status - Published
Essential Drugs Division
e-Tender for the Procurement of Specialty Drugs for the year 2026 -27 - Technical Bid Evaluation - Defects Noticed/ Status - Published - reg.
Essential Drugs Division
e-Tender for the Procurement of Drugs for the year 2026 -27 - Technical Bid Evaluation - Defects Noticed/ Status - Published - reg
Essential Drugs Division
e-Tender for the Procurement of Anti Haemophilic Factors for the year 2025-26-Price Bid Evaluation-Final bid status-Publishing
Essential Drugs Division
e-tender for the Procurement of Drugs/Supplies ( Category III to VIII) for the year 2026-27 – Amendment published – reg
Essential Drugs Division
E-TENDER DOCUMENT FOR THE PROCUREMENT OF DIFLUBENZURON-INSECT GROWTH REGULATOR-LARVICIDE FOR SURVEILLANCE AND CONTROL OF COMMUNICABLE DISEASES UNDER PLAN FUND
Essential Drugs Division
e-TENDER DOCUMENTFOR THE PROCUREMENT OF CHLORINE TABLETS for Surveillance and Control of Communicable Diseases under Plan fund
Essential Drugs Division
KMSCL-e-tender for the Procurement of Specialty Drugs for the year 2026-27- Amendment published-reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Anti-Cancer Drugs for the year 2026-27- Amendment published-reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Drugs/Supplies (Category III & VIII) for the year 2026-27- Amendment published-reg
Essential Drugs Division
KMSCL-e-tender for the Procurement of Drugs (Category I & II) for the year 2026-27- Amendment published-reg
Essential Drugs Division
E-tender for the Procurement of Veterinary Medicines for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid evaluation– Published
Essential Drugs Division
KMSCL- Procurement of Drugs/ Supplies for the year 2026-27- Expression of Interest ( EOI) for Empanelment/ Registration of vendors- reg
Essential Drugs Division
e-Tender Document for the procurement of Biolarvicide :Bacillus Thuringienssi Israeliensis(BTI) For NVBDCP
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs (Category I & II) for the year 2026-27
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs/Supplies (category III-VIII) for the year 2026-27
Essential Drugs Division
KMSCL-e-tender for the procurement of Anti cancer Drugs for the year 2026-27
Essential Drugs Division
E-tender for the Procurement of Recombinant Growth Hormone for SATH under NPRD for the year 2025-26 – Price Bid Evaluation and Provisional bid status– Published
Essential Drugs Division
KMSCL-e-tender for the procurement of Drugs (Category I & II) for the year 2026-27
Essential Drugs Division
E-tender for the Procurement of Veterinary Medicines for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status– Published
Essential Drugs Division
e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2025-26 – Bidders eligible for Price Bid evaluation –Published
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
e-Tender for the Procurement of Drugs & Growth Hormone for the treatment of Rare Disease for the year 2025-26 – Technical Bid Evaluation – status –Published
Essential Drugs Division
KMSCL –Re-tender for the Procurement of Drugs for the year 2025-26 – Price Bid Evaluation – Notice on Supplier wise rate quoted and Provisional Bid Ranking Status– Published – reg
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Drugs for the year 2025-26 -Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg
Essential Drugs Division
- E-tender for the Procurement of Anti Haemophilia Drugs for the year 2025-26 – Technical Bid Evaluation – Defects noticed/status – Published
Essential Drugs Division
KMSCL –Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025- 26–Price Bid Evaluation – Final Bid Status Published – Corrigendum
Essential Drugs Division
E-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 _Change in GST_Revised Final Bid Status Published - Reg
Essential Drugs Division
E-tender for the Procurement of Specialty Drugs for the year 2025-26 – Change in GST– Revised Final Bid Status Published – Reg
Essential Drugs Division
E-tender for the Procurement of Drugs/ Supplies (Category III-VIII) for the year 2025-26 – Change in GST– Revised Final Bid Status Published
Essential Drugs Division
E-tender for the Procurement of Anti-Cancer Drugs for the year 2025-26 – Change in GST– Revised Final Bid Status Published
Essential Drugs Division
LIST OF ITEMS NOT HAVING ELIGIBLE BIDDERS AGAINST THE E-TENDERS FOR THE YEAR 2025-26
Essential Drugs Division
"KMSCL- E- Tender for the Procurement of Veterinary Medicines to Animal Husbandry Department for the year 2025-26.
Essential Drugs Division
KMSCL –Re-Tender for the procurement & supply of Salt testing Kit for NIDDCP for the year 2024-25-Price bid evaluation –Notice on Provisional bid Status Published-reg
Essential Drugs Division
KMSCL- Re-Tender for the procurement & supply of Salt testing Kit for NIDDCP for the year 2024-25- List of selected/ rejected bidder for price bid evaluation –Published-reg
Essential Drugs Division
KMSCL - E-tender for the Procurement of Drugs for the year 2025-26 – Price Bid Evaluation - Final Bid Status - Published
Essential Drugs Division
e-tender for the procurement of Anti Haemophilia Drugs for the year 2025-26 - Time Extension Notice - Published
Essential Drugs Division
E-tender for the Procurement of Drugs (Category I & II) for the year 2025-26 – Rejection of Items offered by M/s. Nandani Medical Laboratories Pvt Ltd & M/s. Healers Lab – Published
Essential Drugs Division
Technical Bid Evaluation/Sample Evaluation-Status of Bidders for Re-Tender for the procurement & supply of Salt testing Kit for NIDDCP for the year 2024-25
Essential Drugs Division
KMSCL E-tender for the Procurement of Drugs for the year 2025-26 Price Bid Evaluation - Notice on Supplier wise rate quoted and Provisional Bid Ranking Status Published reg
Essential Drugs Division
E-tender for the Procurement of Drugs for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for Price Bid Evaluation - Published
Essential Drugs Division
KMSCL - e-TENDER FOR THE PROCUREMENT OF ANTI HAEMOPHILIA DRUGS for the year 2025-26
Essential Drugs Division
Re-tender for the procurement of Drugs/Supplies for the year 2025-26-Price Bid Evaluation- Final Bid Status-Published.Category III-VIII
Essential Drugs Division
Re-tender for the procurement of Drugs for the year 2025-26-Price Bid Evaluation- Final Bid Status-Published
Essential Drugs Division
KMSCL Re-tender for the Procurement of Drugs for the year 2025-26 Price Bid Evaluation Notice on Supplier wise rate quoted and Provisional Bid Ranking Status Published
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Drugs for the year 2025-26 – Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published – reg.
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025 26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
Re-tender for the Procurement of Anti cancer Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
KMSCL – E-tender for the Procurement of Drugs for the year 2025-26Technical Bid Evaluation – Defects noticed/status - Published - reg
Essential Drugs Division
Notice on Final Bid Status of Re-Tender for Procurement & Supply of Drugs for Multiple Sclerosis for KSSM for the year 2025-26
Essential Drugs Division
Re-tender for the procurement of Drugs/Supplies for the year 2025-26-Price Bid Evaluation-Notice on supplier wise rate quoted and provisional Bid Ranking Status -Published
Essential Drugs Division
Re-tender for the procurement of AntiCancerDrugs for the year 2025-26-Price Bid Evaluation-Notice onsupplier wise rate quoted and provisional Bid Ranking Status -Published
Essential Drugs Division
Re-tender for the Procurement of ANTI CANCER DRUGS for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published
Essential Drugs Division
Re-tender for the Procurement of Anti Cancer Drugs for the year 2025 26 - Technical Bid Evaluation – List of selected/rejected bidders/products for price bid evaluation – Published
Essential Drugs Division
e-tender for the Procurement of Drugs for the year 2025-26 – Amendment published
Essential Drugs Division
KMSCL – Re-tender for the Procurement of Anti Cancer Drugs for the year 2025-26 - Technical Bid Evaluation – Defects noticed and status– Published – reg
Essential Drugs Division
Re-tender for the Procurement of Anti Cancer Drugs year 2025-26 - Technical Bid Evaluation–List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
KMSCL - Re-tender for the Procurement of Specialty Drugs for the year 2025-26- Price Bid Evaluation- Final Bid Status - Published - reg
Essential Drugs Division
Re-tender for the Procurement of Drugs for the year 2025-26 –Technical Bid Evaluation -List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
Re-tender for the Procurement of Specialty Drugs for the year 2025-26 - Technical Bid Evaluation –List of selected/rejected bidders/products for price bid evaluation– Published
Essential Drugs Division
KMSCL- e-tender for the procurement of Drugs for Rare Disease for the year 2025-26
Essential Drugs Division
KMSCL- E-tender for the Procurement of Drugs/ Supplies ( category III- VIII) for the year 2025-26- Price Bid Evaluation- Final Bid Status- Published-reg